Test: Difference between revisions
Appearance
Content deleted Content added
No edit summary |
No edit summary |
||
| (15 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
<syntaxhighlight lang="yaml"> |
|||
== Front Page == |
|||
topic: Global insurance markets |
|||
year: 2024 |
|||
source: Activity report - Full Year 2024 |
|||
markets: |
|||
- region: France |
|||
segments: |
|||
- name: Savings insurance |
|||
performance: |
|||
premium_growth_yoy: +14% |
|||
total_premiums_eur_bn: 173 |
|||
sub_products: |
|||
- name: Unit-linked |
|||
growth_yoy: +8% |
|||
share_of_total: 38% # down from 40% in 2023 |
|||
- name: General Account |
|||
growth_yoy: +17% |
|||
notes: |
|||
- Saving ratio increased amid economic, fiscal, and political uncertainty. |
|||
- Stagnant real estate market supported net flows into Life insurance. |
|||
- Surrenders decreased in General Account funds despite Livret A rate held at 3%. |
|||
- Surrenders increased in Unit-linked products, partially offsetting the GA decrease. |
|||
- name: Protection and Complementary Health insurance |
|||
notes: |
|||
- Medical inflation partly absorbed via average tariff increase of 8% in 2024. |
|||
- Cost and frequency of claims both rose. |
|||
- Political uncertainty around the Sécurité Sociale budget may drive further tariff increases as state reimbursement share decreases. |
|||
- name: Property & Casualty |
|||
== Summary == |
|||
notes: |
|||
- Motor claims rose due to driver behavior and higher repair costs. |
|||
natural_catastrophes: |
|||
- event: Cyclone Belal (overseas) |
|||
estimated_cost_eur_bn: 0.1 |
|||
- event: Cyclone Chido (overseas) |
|||
estimated_cost_eur_bn_range: [0.65, 0.8] |
|||
- event: Floods (including Kirk depression) |
|||
estimated_cost_eur_bn_range: [0.35, 0.42] |
|||
- region: Europe (excluding France) |
|||
segments: |
|||
- name: Property & Casualty |
|||
notes: |
|||
- Faced rising repair costs amid persistent but moderating inflation. |
|||
- Evolving risks including climate change. |
|||
- Multiple but less severe weather events, mainly hailstorms and floods across most geographies. |
|||
- Insurers responding via pricing measures, product reshaping, and updated risk management practices. |
|||
- name: Life and Savings |
|||
notes: |
|||
- Recovering from last year's challenging macroeconomic environment. |
|||
- Still affected by modest growth and economic/political uncertainties. |
|||
- name: Health |
|||
== 13. Activity indicators == |
|||
notes: |
|||
- Private insurers facing ageing population, claims cost inflation, and strains on national healthcare systems. |
|||
- Implementing progressive price increases. |
|||
- Focusing on digital transformation, including care pathway management and wellness benefits. |
|||
- region: Japan |
|||
=== 1H24 === |
|||
segments: |
|||
- name: Life insurance |
|||
performance: |
|||
gwp_growth_yoy: +5% |
|||
notes: |
|||
- Growth driven by strong sales of traditional General Account Savings products. |
|||
- Higher guarantees offered as a result of rising Japanese interest rates. |
|||
- Major insurers' net income boosted by favorable Japanese equity market performance. |
|||
- name: Property & Casualty |
|||
{| class="wikitable" style="width:100%" |
|||
performance: |
|||
|+ 📊 AXA Consolidated — Activity Indicators, 1H24 (EUR mm) |
|||
gwp_growth_yoy: +3% |
|||
! style="background:#eaecf0;text-align:left" | |
|||
notes: |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Total |
|||
- Driven by price increases in Motor and Fire insurance. |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | P&C |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Life & Health |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | o/w Employee Benefits** |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Life |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Health |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Asset Management |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Bank |
|||
|- |
|||
| style="text-align:left" | Gross Written Premiums & Other Revenues |
|||
| style="text-align:right" | 59,872 |
|||
| style="text-align:right" | 32,522 |
|||
| style="text-align:right" | 26,505 |
|||
| style="text-align:right" | 6,673 |
|||
| style="text-align:right" | 17,419 |
|||
| style="text-align:right" | 9,086 |
|||
| style="text-align:right" | 787 |
|||
| style="text-align:right" | 57 |
|||
|- |
|||
| style="text-align:left" | IFRS17/9 New Business Value (NBV) (a) |
|||
| style="text-align:right" | 1,206 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 1,206 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 953 |
|||
| style="text-align:right" | 253 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | New Business Contractual Service Margin (NB CSM) |
|||
| style="text-align:right" | 1,131 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 1,131 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 919 |
|||
| style="text-align:right" | 213 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Other NBV * |
|||
| style="text-align:right" | 456 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 456 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 333 |
|||
| style="text-align:right" | 123 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Tax |
|||
| style="text-align:right" | (381) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | (381) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | (299) |
|||
| style="text-align:right" | (83) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Present Value of Expected Premiums (PVEP) (b) |
|||
| style="text-align:right" | 25,588 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 25,588 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 18,234 |
|||
| style="text-align:right" | 7,354 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | IFRS17/9 NBV Margin (a)/(b) |
|||
| style="text-align:right" | 4.7% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 4.7% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 5.2% |
|||
| style="text-align:right" | 3.4% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|} |
|||
- region: Hong Kong |
|||
=== FY24 === |
|||
segments: |
|||
- name: Life insurance |
|||
performance: |
|||
gwp_growth_yoy: +8% |
|||
new_business_growth_yoy: +16% |
|||
notes: |
|||
- New business growth derived from non-Linked individual business. |
|||
- Mainland China Visitors new business slightly decreased vs. 2023. |
|||
- Mainland China Visitors represented 28% of total Individual business. |
|||
- name: Property & Casualty |
|||
{| class="wikitable" style="width:100%" |
|||
notes: |
|||
|+ 📊 AXA Consolidated — Activity Indicators, FY24 (EUR mm) |
|||
- Market remained stable. |
|||
! style="background:#eaecf0;text-align:left" | |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Total |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | P&C |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Life & Health |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | o/w Employee Benefits** |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Life |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Health |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Asset Management |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Bank |
|||
|- |
|||
| style="text-align:left" | Gross Written Premiums & Other Revenues |
|||
| style="text-align:right" | 110,316 |
|||
| style="text-align:right" | 56,514 |
|||
| style="text-align:right" | 51,983 |
|||
| style="text-align:right" | 12,167 |
|||
| style="text-align:right" | 34,497 |
|||
| style="text-align:right" | 17,486 |
|||
| style="text-align:right" | 1,701 |
|||
| style="text-align:right" | 118 |
|||
|- |
|||
| style="text-align:left" | IFRS17/9 New Business Value (NBV) (a) |
|||
| style="text-align:right" | 2,264 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 2,264 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 1,792 |
|||
| style="text-align:right" | 473 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | New Business Contractual Service Margin (NB CSM) |
|||
| style="text-align:right" | 2,169 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 2,169 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 1,770 |
|||
| style="text-align:right" | 399 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Other NBV * |
|||
| style="text-align:right" | 824 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 824 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 594 |
|||
| style="text-align:right" | 231 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Tax |
|||
| style="text-align:right" | (729) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | (729) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | (572) |
|||
| style="text-align:right" | (158) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Present Value of Expected Premiums (PVEP) (b) |
|||
| style="text-align:right" | 50,896 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 50,896 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 36,860 |
|||
| style="text-align:right" | 14,036 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | IFRS17/9 NBV Margin (a)/(b) |
|||
| style="text-align:right" | 4.4% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 4.4% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 4.9% |
|||
| style="text-align:right" | 3.4% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|} |
|||
- region: United States |
|||
=== 1H25 === |
|||
segments: |
|||
- name: Property insurance |
|||
notes: |
|||
- Rates rose, though at a slower pace than prior years. |
|||
- Strict underwriting across capacity deployment, risk selection, and terms and conditions. |
|||
- Adversely impacted by increased frequency of Nat Cat events, particularly secondary perils. |
|||
- Rising reinsurance costs and economic inflation drove up construction costs. |
|||
- name: Casualty insurance |
|||
{| class="wikitable" style="width:100%" |
|||
notes: |
|||
|+ 📊 AXA Consolidated — Activity Indicators (Gross Written Premiums, New Business Value, PVEP, NBV Margin), 1H25, EUR mm |
|||
- Continues to experience rate increases due to loss trends. |
|||
! style="background:#eaecf0;text-align:left" | |
|||
- Elevated casualty claims from social inflation have impacted underwriting margins and reserves. |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Total |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | P&C |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Life & Health |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | o/w Employee Benefits** |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Life |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Health |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Asset Management |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Bank |
|||
|- |
|||
| style="text-align:left" | Gross Written Premiums & Other Revenues |
|||
| style="text-align:right" | 64,251 |
|||
| style="text-align:right" | 34,097 |
|||
| style="text-align:right" | 29,230 |
|||
| style="text-align:right" | 7,223 |
|||
| style="text-align:right" | 19,081 |
|||
| style="text-align:right" | 10,149 |
|||
| style="text-align:right" | 875 |
|||
| style="text-align:right" | 49 |
|||
|- |
|||
| style="text-align:left" | IFRS17/9 New Business Value (NBV) (a) |
|||
| style="text-align:right" | 1,189 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 1,189 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 928 |
|||
| style="text-align:right" | 260 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | New Business Contractual Service Margin (NB CSM) |
|||
| style="text-align:right" | 1,184 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 1,184 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 950 |
|||
| style="text-align:right" | 234 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Other NBV * |
|||
| style="text-align:right" | 382 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 382 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 270 |
|||
| style="text-align:right" | 113 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Tax |
|||
| style="text-align:right" | (378) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | (378) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | (292) |
|||
| style="text-align:right" | (86) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Present Value of Expected Premiums (PVEP) (b) |
|||
| style="text-align:right" | 25,918 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 25,918 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 19,487 |
|||
| style="text-align:right" | 6,430 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | IFRS17/9 NBV Margin (a)/(b) |
|||
| style="text-align:right" | 4.6% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 4.6% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 4.8% |
|||
| style="text-align:right" | 4.0% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|} |
|||
- region: Global |
|||
=== FY25 === |
|||
segments: |
|||
- name: Reinsurance |
|||
{| class="wikitable" style="width:100%" |
|||
notes: |
|||
|+ 📊 AXA Consolidated — Activity Indicators, FY25 (EUR mm) |
|||
- Market remains well-capitalized; companies successfully raised capital to support growth. |
|||
! style="background:#eaecf0;text-align:left" | |
|||
- Property reinsurance saw increased rates and attachment points, improving margins. |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Total |
|||
- Realignment of property catastrophe risk allowed reinsurers to limit losses despite active weather patterns. |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | P&C |
|||
- Strong underwriting performance and improved investment returns helped mitigate adverse prior-year reserve development in US casualty business. |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Life & Health |
|||
</syntaxhighlight> |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | o/w Employee Benefits** |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Life |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Health |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Asset Management |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Bank |
|||
|- |
|||
| style="text-align:left" | Gross Written Premiums & Other Revenues |
|||
| style="text-align:right" | 115,524 |
|||
| style="text-align:right" | 58,038 |
|||
| style="text-align:right" | 56,512 |
|||
| style="text-align:right" | 12,867 |
|||
| style="text-align:right" | 37,499 |
|||
| style="text-align:right" | 19,014 |
|||
| style="text-align:right" | 875 |
|||
| style="text-align:right" | 99 |
|||
|- |
|||
| style="text-align:left" | IFRS17/9 New Business Value (NBV) (a) |
|||
| style="text-align:right" | 2,233 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 2,233 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 1,747 |
|||
| style="text-align:right" | 486 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | New Business Contractual Service Margin (NB CSM) |
|||
| style="text-align:right" | 2,199 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 2,199 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 1,822 |
|||
| style="text-align:right" | 377 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Other NBV * |
|||
| style="text-align:right" | 757 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 757 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 491 |
|||
| style="text-align:right" | 266 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Tax |
|||
| style="text-align:right" | (724) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | (724) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | (567) |
|||
| style="text-align:right" | (157) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Present Value of Expected Premiums (PVEP) (b) |
|||
| style="text-align:right" | 49,357 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 49,357 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 37,103 |
|||
| style="text-align:right" | 12,254 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | IFRS17/9 NBV Margin (a)/(b) |
|||
| style="text-align:right" | 4.5% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 4.5% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 4.7% |
|||
| style="text-align:right" | 4.0% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|} |
|||
=== 1H24 === |
|||
{| class="wikitable" style="width:100%" |
|||
|+ 📊 AXA Consolidated — Activity Indicators (Gross Written Premiums, New Business Value, PVEP & NBV Margin), 1H24, EUR mm |
|||
! style="background:#eaecf0;text-align:left" | |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Total |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | France |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Europe |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | AXA XL |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Asia, Africa & EME-LATAM |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | AXA IM |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Transversal & Other |
|||
|- |
|||
| style="text-align:left" | Gross Written Premiums & Other Revenues |
|||
| style="text-align:right" | 59,872 |
|||
| style="text-align:right" | 14,719 |
|||
| style="text-align:right" | 22,579 |
|||
| style="text-align:right" | 11,220 |
|||
| style="text-align:right" | 9,571 |
|||
| style="text-align:right" | 787 |
|||
| style="text-align:right" | 995 |
|||
|- |
|||
| style="text-align:left" | IFRS17/9 New Business Value (NBV) (a) |
|||
| style="text-align:right" | 1,206 |
|||
| style="text-align:right" | 354 |
|||
| style="text-align:right" | 348 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 504 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | New Business Contractual Service Margin (NB CSM) |
|||
| style="text-align:right" | 1,131 |
|||
| style="text-align:right" | 203 |
|||
| style="text-align:right" | 398 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 531 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Other NBV * |
|||
| style="text-align:right" | 456 |
|||
| style="text-align:right" | 275 |
|||
| style="text-align:right" | 50 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 131 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Tax |
|||
| style="text-align:right" | (381) |
|||
| style="text-align:right" | (123) |
|||
| style="text-align:right" | (100) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | (158) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Present Value of Expected Premiums (PVEP) (b) |
|||
| style="text-align:right" | 25,588 |
|||
| style="text-align:right" | 12,301 |
|||
| style="text-align:right" | 6,317 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 6,971 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | IFRS17/9 NBV Margin (a)/(b) |
|||
| style="text-align:right" | 4.7% |
|||
| style="text-align:right" | 2.9% |
|||
| style="text-align:right" | 5.5% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 7.2% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|} |
|||
* Includes expected profits from short term Life & Health business, carried by Life entities, Pure Investment Contracts, NBV from Equity method entities as well as New Business Loss Components and Margin ceded to reinsurers. |
|||
* Employee Benefits include Group Protection and Group Health contracts. |
|||
=== FY24 === |
|||
{| class="wikitable" style="width:100%" |
|||
|+ 📊 AXA Consolidated — Activity Indicators: Gross Written Premiums & Other Revenues, New Business Value, PVEP and NBV Margin, FY24 (EUR mm) |
|||
! style="background:#eaecf0;text-align:left" | |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Total |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | France |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Europe |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | AXA XL |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Asia, Africa & EME-LATAM |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | AXA IM |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Transversal & Other |
|||
|- |
|||
| style="text-align:left" | Gross Written Premiums & Other Revenues |
|||
| style="text-align:right" | 110,316 |
|||
| style="text-align:right" | 28,996 |
|||
| style="text-align:right" | 39,298 |
|||
| style="text-align:right" | 19,383 |
|||
| style="text-align:right" | 19,083 |
|||
| style="text-align:right" | 1,701 |
|||
| style="text-align:right" | 1,856 |
|||
|- |
|||
| style="text-align:left" | IFRS17/9 New Business Value (NBV) (a) |
|||
| style="text-align:right" | 2,264 |
|||
| style="text-align:right" | 682 |
|||
| style="text-align:right" | 597 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 986 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | New Business Contractual Service Margin (NB CSM) |
|||
| style="text-align:right" | 2,169 |
|||
| style="text-align:right" | 391 |
|||
| style="text-align:right" | 731 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 1,047 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Other NBV * |
|||
| style="text-align:right" | 824 |
|||
| style="text-align:right" | 528 |
|||
| style="text-align:right" | 49 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 247 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Tax |
|||
| style="text-align:right" | (729) |
|||
| style="text-align:right" | (237) |
|||
| style="text-align:right" | (184) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | (309) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Present Value of Expected Premiums (PVEP) (b) |
|||
| style="text-align:right" | 50,896 |
|||
| style="text-align:right" | 25,370 |
|||
| style="text-align:right" | 11,831 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 13,695 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | IFRS17/9 NBV Margin (a)/(b) |
|||
| style="text-align:right" | 4.4% |
|||
| style="text-align:right" | 2.7% |
|||
| style="text-align:right" | 5.0% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 7.2% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|} |
|||
* Includes expected profits from short term Life & Health business, carried by Life entities, Pure Investment Contracts, NBV from Equity method entities as well as New Business Loss Components and Margin ceded to reinsurers. |
|||
* Employee Benefits include Group Protection and Group Health contracts. |
|||
=== 1H25 === |
|||
{| class="wikitable" style="width:100%" |
|||
|+ 📊 AXA Consolidated — Activity Indicators, 1H25 (EUR mm) |
|||
! style="background:#eaecf0;text-align:left" | |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Total |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | France |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Europe |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | AXA XL |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Asia, Africa & EME-LATAM |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | AXA IM |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Transversal & Other |
|||
|- |
|||
| style="text-align:left" | Gross Written Premiums & Other Revenues |
|||
| style="text-align:right" | 64,251 |
|||
| style="text-align:right" | 15,670 |
|||
| style="text-align:right" | 24,649 |
|||
| style="text-align:right" | 11,749 |
|||
| style="text-align:right" | 10,302 |
|||
| style="text-align:right" | 875 |
|||
| style="text-align:right" | 1,006 |
|||
|- |
|||
| style="text-align:left" | IFRS17/9 New Business Value (NBV) (a) |
|||
| style="text-align:right" | 1,189 |
|||
| style="text-align:right" | 315 |
|||
| style="text-align:right" | 364 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 510 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | New Business Contractual Service Margin (NB CSM) |
|||
| style="text-align:right" | 1,184 |
|||
| style="text-align:right" | 199 |
|||
| style="text-align:right" | 443 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 541 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Other NBV * |
|||
| style="text-align:right" | 382 |
|||
| style="text-align:right" | 225 |
|||
| style="text-align:right" | 28 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 129 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Tax |
|||
| style="text-align:right" | (378) |
|||
| style="text-align:right" | (109) |
|||
| style="text-align:right" | (107) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | (161) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Present Value of Expected Premiums (PVEP) (b) |
|||
| style="text-align:right" | 25,918 |
|||
| style="text-align:right" | 11,662 |
|||
| style="text-align:right" | 6,843 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 7,413 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | IFRS17/9 NBV Margin (a)/(b) |
|||
| style="text-align:right" | 4.6% |
|||
| style="text-align:right" | 2.7% |
|||
| style="text-align:right" | 5.3% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 6.9% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|} |
|||
* Includes expected profits from short term Life & Health business, carried by Life entities, Pure Investment Contracts, NBV from Equity method entities as well as New Business Loss Components and Margin ceded to reinsurers. |
|||
* Employee Benefits include Group Protection and Group Health contracts. |
|||
=== FY25 === |
|||
{| class="wikitable" style="width:100%" |
|||
|+ 📊 AXA Consolidated — Activity Indicators: Gross Written Premiums & Other Revenues, New Business Value, PVEP and NBV Margin (EUR mm), FY25 |
|||
! style="background:#eaecf0;text-align:left" | |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Total |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | France |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Europe |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | AXA XL |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Asia, Africa & EME-LATAM |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | AXA IM |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | Transversal & Other |
|||
|- |
|||
| style="text-align:left" | Gross Written Premiums & Other Revenues |
|||
| style="text-align:right" | 115,524 |
|||
| style="text-align:right" | 30,598 |
|||
| style="text-align:right" | 43,005 |
|||
| style="text-align:right" | 19,277 |
|||
| style="text-align:right" | 19,925 |
|||
| style="text-align:right" | 875 |
|||
| style="text-align:right" | 1,844 |
|||
|- |
|||
| style="text-align:left" | IFRS17/9 New Business Value (NBV) (a) |
|||
| style="text-align:right" | 2,233 |
|||
| style="text-align:right" | 695 |
|||
| style="text-align:right" | 578 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 959 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | New Business Contractual Service Margin (NB CSM) |
|||
| style="text-align:right" | 2,199 |
|||
| style="text-align:right" | 431 |
|||
| style="text-align:right" | 740 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 1,028 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Other NBV * |
|||
| style="text-align:right" | 757 |
|||
| style="text-align:right" | 506 |
|||
| style="text-align:right" | 12 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 239 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Tax |
|||
| style="text-align:right" | (724) |
|||
| style="text-align:right" | (242) |
|||
| style="text-align:right" | (174) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | (308) |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Present Value of Expected Premiums (PVEP) (b) |
|||
| style="text-align:right" | 49,357 |
|||
| style="text-align:right" | 22,858 |
|||
| style="text-align:right" | 12,651 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 13,847 |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | IFRS17/9 NBV Margin (a)/(b) |
|||
| style="text-align:right" | 4.5% |
|||
| style="text-align:right" | 3.0% |
|||
| style="text-align:right" | 4.6% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 6.9% |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|} |
|||
* Includes expected profits from short term Life & Health business, carried by Life entities, Pure Investment Contracts, NBV from Equity method entities as well as New Business Loss Components and Margin ceded to reinsurers. |
|||
* Employee Benefits include Group Protection and Group Health contracts. |
|||
== 14. Balance Sheet == |
|||
=== Assets === |
|||
{| class="wikitable" style="width:100%" |
|||
|+ 📊 AXA — Consolidated Balance Sheet, FY24–FY25 (EUR bn) |
|||
! style="background:#eaecf0;text-align:left" | |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | FY24 |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | FY25 |
|||
! style="background:#eaecf0;text-align:left;width:9em;" | Liabilities, Non-controlling Interests & Shareholders' Equity |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | FY24 |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | FY25 |
|||
|- |
|||
| style="text-align:left" | Goodwill |
|||
| style="text-align:right" | 18.1 |
|||
| style="text-align:right" | 17.8 |
|||
| style="text-align:left" | Shareholders' Equity group share |
|||
| style="text-align:right" | 49.9 |
|||
| style="text-align:right" | 47.2 |
|||
|- |
|||
| style="text-align:left" | Other intangible assets |
|||
| style="text-align:right" | 4.4 |
|||
| style="text-align:right" | 4.4 |
|||
| style="text-align:left" | Non-controlling Interests |
|||
| style="text-align:right" | 2.5 |
|||
| style="text-align:right" | 2.4 |
|||
|- |
|||
| style="background:#f8f9fa;border-top:1px solid #a2a9b1;text-align:left" | '''Total Intangible assets''' |
|||
| style="background:#f8f9fa;text-align:right" | '''22.6''' |
|||
| style="background:#f8f9fa;text-align:right" | '''22.2''' |
|||
| style="background:#f8f9fa;text-align:left" | '''Shareholders’ equity''' |
|||
| style="background:#f8f9fa;text-align:right" | '''52.5''' |
|||
| style="background:#f8f9fa;text-align:right" | '''49.6''' |
|||
|- |
|||
| style="text-align:left" | Investments in real estate properties |
|||
| style="text-align:right" | 29.2 |
|||
| style="text-align:right" | 27.8 |
|||
| style="text-align:left" | Financing debt |
|||
| style="text-align:right" | 14.4 |
|||
| style="text-align:right" | 15.8 |
|||
|- |
|||
| style="text-align:left" | Financial investments |
|||
| style="text-align:right" | 418.2 |
|||
| style="text-align:right" | 401.8 |
|||
| style="text-align:left" | Liabilities arising from insurance contracts and investment contracts with discretionary participation features contracts |
|||
| style="text-align:right" | 477.0 |
|||
| style="text-align:right" | 470.4 |
|||
|- |
|||
| style="text-align:left" | Unit-linked Assets |
|||
| style="text-align:right" | 90.1 |
|||
| style="text-align:right" | 97.2 |
|||
| style="text-align:left" | Present Value of Future Cash Flows |
|||
| style="text-align:right" | 438.4 |
|||
| style="text-align:right" | 432.6 |
|||
|- |
|||
| style="background:#f8f9fa;border-top:1px solid #a2a9b1;text-align:left" | '''Total Investments from Insurance activities''' |
|||
| style="background:#f8f9fa;text-align:right" | '''537.5''' |
|||
| style="background:#f8f9fa;text-align:right" | '''526.9''' |
|||
| style="background:#f8f9fa;text-align:left" | '''Contractual Service Margin''' |
|||
| style="background:#f8f9fa;text-align:right" | '''35.3''' |
|||
| style="background:#f8f9fa;text-align:right" | '''34.7''' |
|||
|- |
|||
| style="text-align:left" | Investments from Non-Insurance Activities |
|||
| style="text-align:right" | 18.5 |
|||
| style="text-align:right" | 16.6 |
|||
| style="text-align:left" | Risk Adjustment |
|||
| style="text-align:right" | 3.3 |
|||
| style="text-align:right" | 3.1 |
|||
|- |
|||
| style="text-align:left" | Equity Method investments |
|||
| style="text-align:right" | 1.5 |
|||
| style="text-align:right" | 1.5 |
|||
| style="text-align:left" | Other Investment Contract Liabilities |
|||
| style="text-align:right" | 12.6 |
|||
| style="text-align:right" | 12.8 |
|||
|- |
|||
| style="background:#f8f9fa;border-top:1px solid #a2a9b1;text-align:left" | '''Assets Arising from Insurance and Reinsurance Contracts Held''' |
|||
| style="background:#f8f9fa;text-align:right" | '''26.1''' |
|||
| style="background:#f8f9fa;text-align:right" | '''23.9''' |
|||
| style="background:#f8f9fa;text-align:left" | '''Liabilities arising from insurance, reinsurance and investment contracts''' |
|||
| style="background:#f8f9fa;text-align:right" | '''489.6''' |
|||
| style="background:#f8f9fa;text-align:right" | '''483.2''' |
|||
|- |
|||
| style="text-align:left" | Present Value of Future Cash Flows |
|||
| style="text-align:right" | 24.1 |
|||
| style="text-align:right" | 22.0 |
|||
| style="text-align:left" | Liabilities Arising from Non-Insurance Activities |
|||
| style="text-align:right" | 10.1 |
|||
| style="text-align:right" | 9.9 |
|||
|- |
|||
| style="text-align:left" | Contractual Service Margin |
|||
| style="text-align:right" | 1.4 |
|||
| style="text-align:right" | 1.4 |
|||
| style="text-align:left" | Provisions for risks and charges |
|||
| style="text-align:right" | 4.9 |
|||
| style="text-align:right" | 4.6 |
|||
|- |
|||
| style="text-align:left" | Risk Adjustment |
|||
| style="text-align:right" | 0.5 |
|||
| style="text-align:right" | 0.5 |
|||
| style="text-align:left" | Payables and Other liabilities |
|||
| style="text-align:right" | 80.9 |
|||
| style="text-align:right" | 72.5 |
|||
|- |
|||
| style="text-align:left" | Receivables and Other Assets |
|||
| style="text-align:right" | 24.1 |
|||
| style="text-align:right" | 21.9 |
|||
| style="text-align:left" | Liabilities held for sale |
|||
| style="text-align:right" | 1.4 |
|||
| style="text-align:right" | 0.0 |
|||
|- |
|||
| style="text-align:left" | Assets held for sale |
|||
| style="text-align:right" | 4.5 |
|||
| style="text-align:right" | 0.2 |
|||
| style="text-align:left" | Total Liabilities, Non-controlling Interests and Shareholders' Equity |
|||
| style="text-align:right" | 653.8 |
|||
| style="text-align:right" | 635.5 |
|||
|- |
|||
| style="text-align:left" | Cash and cash equivalents |
|||
| style="text-align:right" | 19.0 |
|||
| style="text-align:right" | 22.2 |
|||
| style="text-align:left" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="background:#f8f9fa;border-top:1px solid #a2a9b1;text-align:left" | '''Total Assets''' |
|||
| style="background:#f8f9fa;text-align:right" | '''653.8''' |
|||
| style="background:#f8f9fa;text-align:right" | '''635.5''' |
|||
| style="background:#f8f9fa;text-align:left" | '''—''' |
|||
| style="background:#f8f9fa;text-align:right" | '''—''' |
|||
| style="background:#f8f9fa;text-align:right" | '''—''' |
|||
|} |
|||
=== Liabilities, Non-controlling Interests & Shareholders' Equity === |
|||
{| class="wikitable" style="width:100%" |
|||
|+ 📊 AXA Consolidated — Balance Sheet: Liabilities, Non-controlling Interests & Shareholders' Equity (EUR bn), FY24–FY25 |
|||
! style="background:#eaecf0;text-align:left" | |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | FY24 |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | FY25 |
|||
! style="background:#eaecf0;text-align:left;width:9em;" | Liabilities, Non-controlling Interests & Shareholders' Equity |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | FY24 |
|||
! style="background:#eaecf0;text-align:right;width:6em;" | FY25 |
|||
|- |
|||
| style="text-align:left" | Goodwill |
|||
| style="text-align:right" | 18.1 |
|||
| style="text-align:right" | 17.8 |
|||
| style="text-align:left" | Shareholders' Equity group share |
|||
| style="text-align:right" | 49.9 |
|||
| style="text-align:right" | 47.2 |
|||
|- |
|||
| style="text-align:left" | Other intangible assets |
|||
| style="text-align:right" | 4.4 |
|||
| style="text-align:right" | 4.4 |
|||
| style="text-align:left" | Non-controlling Interests |
|||
| style="text-align:right" | 2.5 |
|||
| style="text-align:right" | 2.4 |
|||
|- |
|||
| style="background:#f8f9fa;border-top:1px solid #a2a9b1;text-align:left" | ''' Total Intangible assets''' |
|||
| style="background:#f8f9fa;text-align:right" | '''22.6''' |
|||
| style="background:#f8f9fa;text-align:right" | '''22.2''' |
|||
| style="background:#f8f9fa;text-align:left" | '''Shareholders’ equity''' |
|||
| style="background:#f8f9fa;text-align:right" | '''52.5''' |
|||
| style="background:#f8f9fa;text-align:right" | '''49.6''' |
|||
|- |
|||
| style="text-align:left" | Investments in real estate properties |
|||
| style="text-align:right" | 29.2 |
|||
| style="text-align:right" | 27.8 |
|||
| style="text-align:left" | Financing debt |
|||
| style="text-align:right" | 14.4 |
|||
| style="text-align:right" | 15.8 |
|||
|- |
|||
| style="background:#f8f9fa;border-top:1px solid #a2a9b1;text-align:left" | '''Financial investments''' |
|||
| style="background:#f8f9fa;text-align:right" | '''418.2''' |
|||
| style="background:#f8f9fa;text-align:right" | '''401.8''' |
|||
| style="background:#f8f9fa;text-align:left" | '''Liabilities arising from insurance contracts and investment contracts with discretionary participation features contracts''' |
|||
| style="background:#f8f9fa;text-align:right" | '''477.0''' |
|||
| style="background:#f8f9fa;text-align:right" | '''470.4''' |
|||
|- |
|||
| style="text-align:left" | Unit-linked Assets |
|||
| style="text-align:right" | 90.1 |
|||
| style="text-align:right" | 97.2 |
|||
| style="text-align:left" | Present Value of Future Cash Flows |
|||
| style="text-align:right" | 438.4 |
|||
| style="text-align:right" | 432.6 |
|||
|- |
|||
| style="text-align:left" | Total Investments from Insurance activities |
|||
| style="text-align:right" | 537.5 |
|||
| style="text-align:right" | 526.9 |
|||
| style="text-align:left" | Contractual Service Margin |
|||
| style="text-align:right" | 35.3 |
|||
| style="text-align:right" | 34.7 |
|||
|- |
|||
| style="text-align:left" | Investments from Non-Insurance Activities |
|||
| style="text-align:right" | 18.5 |
|||
| style="text-align:right" | 16.6 |
|||
| style="text-align:left" | Risk Adjustment |
|||
| style="text-align:right" | 3.3 |
|||
| style="text-align:right" | 3.1 |
|||
|- |
|||
| style="text-align:left" | Equity Method investments |
|||
| style="text-align:right" | 1.5 |
|||
| style="text-align:right" | 1.5 |
|||
| style="text-align:left" | Other Investment Contract Liabilities |
|||
| style="text-align:right" | 12.6 |
|||
| style="text-align:right" | 12.8 |
|||
|- |
|||
| style="background:#f8f9fa;border-top:1px solid #a2a9b1;text-align:left" | '''Assets Arising from Insurance and Reinsurance Contracts Held''' |
|||
| style="background:#f8f9fa;text-align:right" | '''26.1''' |
|||
| style="background:#f8f9fa;text-align:right" | '''23.9''' |
|||
| style="background:#f8f9fa;text-align:left" | '''Liabilities arising from insurance, reinsurance and investment contracts''' |
|||
| style="background:#f8f9fa;text-align:right" | '''489.6''' |
|||
| style="background:#f8f9fa;text-align:right" | '''483.2''' |
|||
|- |
|||
| style="text-align:left" | Present Value of Future Cash Flows |
|||
| style="text-align:right" | 24.1 |
|||
| style="text-align:right" | 22.0 |
|||
| style="text-align:left" | Liabilities Arising from Non-Insurance Activities |
|||
| style="text-align:right" | 10.1 |
|||
| style="text-align:right" | 9.9 |
|||
|- |
|||
| style="text-align:left" | Contractual Service Margin |
|||
| style="text-align:right" | 1.4 |
|||
| style="text-align:right" | 1.4 |
|||
| style="text-align:left" | Provisions for risks and charges |
|||
| style="text-align:right" | 4.9 |
|||
| style="text-align:right" | 4.6 |
|||
|- |
|||
| style="text-align:left" | Risk Adjustment |
|||
| style="text-align:right" | 0.5 |
|||
| style="text-align:right" | 0.5 |
|||
| style="text-align:left" | Payables and Other liabilities |
|||
| style="text-align:right" | 80.9 |
|||
| style="text-align:right" | 72.5 |
|||
|- |
|||
| style="text-align:left" | Receivables and Other Assets |
|||
| style="text-align:right" | 24.1 |
|||
| style="text-align:right" | 21.9 |
|||
| style="text-align:left" | Liabilities held for sale |
|||
| style="text-align:right" | 1.4 |
|||
| style="text-align:right" | 0.0 |
|||
|- |
|||
| style="background:#f8f9fa;border-top:1px solid #a2a9b1;text-align:left" | '''Assets held for sale''' |
|||
| style="background:#f8f9fa;text-align:right" | '''4.5''' |
|||
| style="background:#f8f9fa;text-align:right" | '''0.2''' |
|||
| style="background:#f8f9fa;text-align:left" | '''Total Liabilities, Non-controlling Interests and Shareholders' Equity''' |
|||
| style="background:#f8f9fa;text-align:right" | '''653.8''' |
|||
| style="background:#f8f9fa;text-align:right" | '''635.5''' |
|||
|} |
|||
Latest revision as of 16:48, 27 April 2026
topic: Global insurance markets
year: 2024
source: Activity report - Full Year 2024
markets:
- region: France
segments:
- name: Savings insurance
performance:
premium_growth_yoy: +14%
total_premiums_eur_bn: 173
sub_products:
- name: Unit-linked
growth_yoy: +8%
share_of_total: 38% # down from 40% in 2023
- name: General Account
growth_yoy: +17%
notes:
- Saving ratio increased amid economic, fiscal, and political uncertainty.
- Stagnant real estate market supported net flows into Life insurance.
- Surrenders decreased in General Account funds despite Livret A rate held at 3%.
- Surrenders increased in Unit-linked products, partially offsetting the GA decrease.
- name: Protection and Complementary Health insurance
notes:
- Medical inflation partly absorbed via average tariff increase of 8% in 2024.
- Cost and frequency of claims both rose.
- Political uncertainty around the Sécurité Sociale budget may drive further tariff increases as state reimbursement share decreases.
- name: Property & Casualty
notes:
- Motor claims rose due to driver behavior and higher repair costs.
natural_catastrophes:
- event: Cyclone Belal (overseas)
estimated_cost_eur_bn: 0.1
- event: Cyclone Chido (overseas)
estimated_cost_eur_bn_range: [0.65, 0.8]
- event: Floods (including Kirk depression)
estimated_cost_eur_bn_range: [0.35, 0.42]
- region: Europe (excluding France)
segments:
- name: Property & Casualty
notes:
- Faced rising repair costs amid persistent but moderating inflation.
- Evolving risks including climate change.
- Multiple but less severe weather events, mainly hailstorms and floods across most geographies.
- Insurers responding via pricing measures, product reshaping, and updated risk management practices.
- name: Life and Savings
notes:
- Recovering from last year's challenging macroeconomic environment.
- Still affected by modest growth and economic/political uncertainties.
- name: Health
notes:
- Private insurers facing ageing population, claims cost inflation, and strains on national healthcare systems.
- Implementing progressive price increases.
- Focusing on digital transformation, including care pathway management and wellness benefits.
- region: Japan
segments:
- name: Life insurance
performance:
gwp_growth_yoy: +5%
notes:
- Growth driven by strong sales of traditional General Account Savings products.
- Higher guarantees offered as a result of rising Japanese interest rates.
- Major insurers' net income boosted by favorable Japanese equity market performance.
- name: Property & Casualty
performance:
gwp_growth_yoy: +3%
notes:
- Driven by price increases in Motor and Fire insurance.
- region: Hong Kong
segments:
- name: Life insurance
performance:
gwp_growth_yoy: +8%
new_business_growth_yoy: +16%
notes:
- New business growth derived from non-Linked individual business.
- Mainland China Visitors new business slightly decreased vs. 2023.
- Mainland China Visitors represented 28% of total Individual business.
- name: Property & Casualty
notes:
- Market remained stable.
- region: United States
segments:
- name: Property insurance
notes:
- Rates rose, though at a slower pace than prior years.
- Strict underwriting across capacity deployment, risk selection, and terms and conditions.
- Adversely impacted by increased frequency of Nat Cat events, particularly secondary perils.
- Rising reinsurance costs and economic inflation drove up construction costs.
- name: Casualty insurance
notes:
- Continues to experience rate increases due to loss trends.
- Elevated casualty claims from social inflation have impacted underwriting margins and reserves.
- region: Global
segments:
- name: Reinsurance
notes:
- Market remains well-capitalized; companies successfully raised capital to support growth.
- Property reinsurance saw increased rates and attachment points, improving margins.
- Realignment of property catastrophe risk allowed reinsurers to limit losses despite active weather patterns.
- Strong underwriting performance and improved investment returns helped mitigate adverse prior-year reserve development in US casualty business.